Biolex, Inc

Biolex Therapeutics applies its unique drug development capabilities and expertise to commercialize complex proteins and monoclonal antibodies that until now have been impossible or very expensive to develop through traditional means. The company is advancing a proprietary pipeline of product candidates including Locteron™, a next-generation controlled-release form of alfa interferon which entered Phase 1 clinical trials in 2005. Biolex has an extensive, multi-protein strategic alliance with Centocor and collaborations with other pharmaceutical/biotech companies including Medarex, MedImmune, and OctoPlus.

Contact Details: 158 Credle Street Pittsboro North Carolina 27312 United States of America Tel: 919.542.9901 Fax: 919.542.9910 Email: hr@biolex.com WWW: www.biolex.com/

Loading...

Biolex, Inc Patents:
US Patent No.	Title
7176024	Bioreactor for growing biological materials supported on a liquid surface
7160717	LED array for illuminating cell well plates and automated rack system for handling the same
6815184	Expression of biologically active polypeptide in duckweed
6680200	Led array for illuminating cell well plates and automated rack system for handling the same

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 226 times since April 2007, the link to the organisation's website has been followed 47 times

Search for more companies in Pittsboro

Search for more companies in North Carolina

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Biolex, Inc